Sartorius and Science magazine to award prize for regenerative medicine and cell therapy
Sartorius together with the Science magazine will award a Sartorius & Science Prize for regenerative medicine & Cell Therapy. This prestigious annual award is geared towards exceptional scientists who focus on achieving advancements in basic or translational research in these areas. All scientists who have earned a Ph.D. or an M.D. within the past ten years may submit an essay on regenerative medicine, cell therapy, gene therapy or immunotherapy, as well as on materials or tissue engineering.
The winner of the Sartorius & Science Prize for Regenerative Medicine & Cell Therapy will be awarded U.S. $25,000 and have his or her essay printed in Science magazine. In addition, the winner will receive an attractive Sartorius product package gratis. Moreover, the grand prize essay and those of up to three runners-up will be published in Science Online. Runners-up will receive prize money of U.S. $5,000.
Regenerative medicine and cell therapy address stimulation of the body’s repair mechanisms. Furthermore, these therapeutic approaches can lead to technologies allowing tissue and transplantable organs to be grown in the lab. “This area will play a major role in the future. Sartorius’ innovative bioanalytical tools help scientists answer fundamental and complex biological questions. We are excited to enable medical progress in these fields, both with our technologies and this award. The prize will be conferred as a token of appreciation to scientists,” said Gerry MacKay, member of the Sartorius Group Executive Committee and Executive Vice President of Marketing, Sales and Services for Sartorius’ Lab Products & Services Division.
Founded by Thomas Edison, Science is published by the American Association for the Advancement of Science (AAAS), the world's largest general scientific society. “Science is delighted to join Sartorius in awarding a prize in the exciting area of regenerative medicine and cell therapy. We look forward to promoting basic or translational research in fields ranging from gene therapy to materials engineering, which has the potential to improve human health,” said Valda J. Vinson, Deputy Editor Research of Science.
Applicants need to submit a 1,000-word essay describing their research and implications for regenerative medicine and cell immunotherapy, as well as supporting documents. The application deadline is October 1, 2017. The awards ceremony will be held in 2018 in Goettingen, Germany.
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
More news from our other portals
See the theme worlds for related content
Topic world Gene therapy
Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.
Topic world Gene therapy
Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.
